Anterogen.Co.Ltd
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn's fistula; Queencell, a stromal vascular fraction used for the regen… Read more
Anterogen.Co.Ltd (065660) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Anterogen.Co.Ltd (065660) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩281.98 Million) by net assets (₩90.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anterogen.Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Anterogen.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Anterogen.Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anterogen.Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arnoldo Mondadori Editore S.p.A.
LSE:0KAV
|
-0.002x |
|
Wuhan Xingtu Xinke Electronics Co Ltd
SHG:688081
|
-0.047x |
|
Yanlord Land Group Limited
PINK:YLDGF
|
-0.016x |
|
Immobiliare Grande Distribuzione SIIQ SpA
LSE:0STP
|
0.023x |
|
Hubei Forbon Technology Co Ltd
SHE:300387
|
0.007x |
|
Blackline Safety Corp
PINK:BLKLF
|
0.009x |
|
Orient Electric Limited
NSE:ORIENTELEC
|
-0.059x |
|
Tianjin Hi-Tech Development Co Ltd
SHG:600082
|
0.298x |
Annual Cash Flow Conversion Efficiency for Anterogen.Co.Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Anterogen.Co.Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩110.21 Billion | ₩-860.38 Million | -0.008x | +49.17% |
| 2023-12-31 | ₩129.44 Billion | ₩-1.99 Billion | -0.015x | +16.96% |
| 2022-12-31 | ₩106.79 Billion | ₩-1.98 Billion | -0.018x | +29.02% |
| 2021-12-31 | ₩116.87 Billion | ₩-3.05 Billion | -0.026x | +52.15% |
| 2020-12-31 | ₩81.07 Billion | ₩-4.41 Billion | -0.054x | -125.90% |
| 2019-12-31 | ₩68.39 Billion | ₩-1.65 Billion | -0.024x | +10.16% |
| 2018-12-31 | ₩56.07 Billion | ₩-1.50 Billion | -0.027x | -429.83% |
| 2017-12-31 | ₩46.61 Billion | ₩379.21 Million | 0.008x | +311.89% |
| 2016-12-31 | ₩34.02 Billion | ₩-130.65 Million | -0.004x | -107.57% |
| 2015-12-31 | ₩16.64 Billion | ₩844.49 Million | 0.051x | +165.11% |
| 2014-12-31 | ₩12.96 Billion | ₩-1.01 Billion | -0.078x | -- |